Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-12-14FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic valsartan/hydrochlorothiazide fixed-dose combination from Mylan Pharmaceuticals, e…
-
FDA approval · 2012-12-11FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR, the brand-name combination of amlodipine besylate and olmesartan medoxomil, by Cosette Pha…
-
FDA approval · 2012-12-11FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide) submitted by Cosette Pharmaceuticals, Inc…
-
FDA approval · 2012-12-10FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals, Inc.'s supplemental application for Tribenzor, a fixed-dose combination of olmesartan medoxomil, amlod…
-
FDA approval · 2012-12-07FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s generic diltiazem hydrochloride (ANDA 202463). The product is indicated for the management of hypertensi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-12-07FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved a generic hydralazine hydrochloride product under Original Application ANDA200737 from Ascend Laboratories, LLC.
-
FDA approval · 2012-12-05FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market Irbesartan and Hydrochlorothiazide as a fixed-dos…
-
FDA approval · 2012-12-04FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved an original ANDA for a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide by Mylan Pharmaceuticals Inc…
-
FDA approval · 2012-11-30FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)
The FDA approved a supplemental application for furosemide from Ipca Laboratories Limited, indicating approval of their generic furosemide p…
-
FDA approval · 2012-11-28FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Exforge (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation. This acti…
-
FDA approval · 2012-11-28FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EXFORGE HCT, a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide, fil…
-
FDA approval · 2012-11-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc. for an already authorized product.
-
FDA approval · 2012-11-14FDA Approved: IRBESARTAN — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original Abbreviated New Drug Application for irbesartan, enabling a generic version of the medication.
-
FDA approval · 2012-11-08FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for benazepril hydrochloride from Aurobindo Pharma Limited. Benazepril hydrochloride is a generic AC…
-
FDA approval · 2012-11-08FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Benazepril hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2012-11-08FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for benazepril hydrochloride tablets from Solco Healthcare U.S., LLC, enabling the generic produ…
-
FDA approval · 2012-10-31FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of amlodipine besylate and atorvastatin calcium, manufactured by …
-
FDA approval · 2012-10-31FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
The FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) from Almatica Pharma Inc., under NDA 019888.
-
FDA approval · 2012-10-31FDA Approved: TENORETIC — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for Tenoretic (atenolol and chlorthalidone) submitted by Upsher-Smith Laboratories.
-
FDA approval · 2012-10-24FDA Approved: MICARDIS HCT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for MICARDIS HCT (telmisartan and hydrochlorothiazide) submitted by Boehringer Ingelheim Pharmac…
-
FDA approval · 2012-10-15FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a generic fixed-dose combination of irbesartan and hydrochlorothiazide (IRBESARTAN AND HYDROCHLOROTHIAZIDE). The approval was i…
-
FDA approval · 2012-10-15FDA Approved: IRBESARTAN — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original ANDA for Irbesartan, a generic angiotensin II receptor blocker for hypertension.
-
FDA approval · 2012-10-15FDA Approved: IRBESARTAN — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for irbesartan, a generic angiotensin II receptor blocker for hypertension and …
-
FDA approval · 2012-10-05FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis Pharmaceuticals Corporat…
-
FDA approval · 2012-10-05FDA Approved: GUANFACINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s Guanfacine as an original generic application (ANDA 200881), authorizing the manufacture and marketing o…